SCHEMBL29469810

SCHEMBL29469810

Cc1ccc(OC(C)C)c(S(=O)(=O)NC(=O)c2cc3c(F)cc(N4CC(F)C4)cc3o2)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.34
TP53 P04637 1/20 0.34
DRD2 P14416 1/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
LMNA P02545 1/20 0.33
KMT2A Q03164 5/20 0.33
GAA P10253 2/20 0.32
MEN1 O00255 4/20 0.32
PTGDR Q13258 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
KAT6A Q92794 1/20 0.32
POLB P06746 3/20 0.31
THRB P10828 2/20 0.31
HPGD P15428 2/20 0.31
CPT2 P23786 1/20 0.31
CPT1A P50416 1/20 0.31
CPT1B Q92523 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24334009 1.00 MAPT (0.34) MAPTTP53DRD2ADRA1DADRA1A
SCHEMBL29469665 0.90 ADRA1A (0.35) MAPTDRD2ADRA1DADRA1AADRA1B
SCHEMBL29469724 0.90 MAPT (0.39) MAPTTP53DRD2ADRA1DADRA1A
SCHEMBL24333981 0.90 MAPT (0.39) MAPTTP53DRD2ADRA1DADRA1A
SCHEMBL24334327 0.86 KEAP1 (0.38) LMNAKMT2AGAAMEN1POLB
SCHEMBL24333724 0.83 MAPT (0.37) MAPTTP53LMNAKMT2AGAA
SCHEMBL29469654 0.83 MAPT (0.37) MAPTTP53LMNAKMT2AGAA
SCHEMBL24334309 0.82 ALDH1A1 (0.41) MAPTLMNAKMT2AMEN1ALDH1A1
SCHEMBL24333697 0.81 ALDH1A1 (0.41) MAPTLMNAKMT2AMEN1KDM4E
SCHEMBL24333713 0.81 MEN1 (0.37) MAPTTP53DRD2ADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed